News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Merck & Co., Inc. (MRK) Loses Patent Ruling Over Zetia



4/26/2010 5:11:04 PM

Pharmalot -- Merck just lost some patent protection on its Zetia cholesterol drug. A federal judge in Newark, New Jersey, invalidated several items that were added in 2002, when Schering-Plough (now owned by Merck) obtained a reissued patent. But US District Court Judge Jose Linares ruled the patent shouldn’t have been reissued because a valid and enforceable one already exists, The New Jersey Law Journal reports.

Read at Pharmalot


comments powered by Disqus
Pharmalot
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES